# Biotech Daily Digest â€” 2025-11-25

**65 items from 5 sources**

## Summary by Source

- Eli Lilly Press Releases: 2 items
- Endpoints News: 10 items
- Fierce Biotech: 7 items
- Regeneron Press Releases: 1 item
- arXiv q-bio: 45 items


## Eli Lilly Press Releases

- **[Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium](https://investor.lilly.com/news-releases/news-release-details/lilly-highlight-progress-across-key-programs-early-and-advanced)**  
  _Mon, 24 Nov 2025 16:30:00 -0500_  
  Updated results from the Phase 3 EMBER-3 trial for Inluriyoâ„¢ (imlunestrant) alone and in combination with Verzenio Â® (abemaciclib) in ER+, HER2 â€“ metastatic breast cancer to be presented as a late-breaking oral presentation Updated safety and efficacy data to be presented from PIKALO-1, the Phase

- **[Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting](https://investor.lilly.com/news-releases/news-release-details/lilly-present-data-two-positive-phase-3-studies-jaypirca)**  
  _Mon, 24 Nov 2025 12:00:00 -0500_  
  Results from the BRUIN CLL-314 study comparing Jaypirca (pirtobrutinib) to Imbruvica (ibrutinib) â€“ the first-ever head-to-head Phase 3 study versus a covalent BTK inhibitor to include treatment-naÃ¯ve CLL/SLL patients â€“ will be presented as an oral presentation Results from the Phase 3 BRUIN CLL-313


## Endpoints News

- **[Novo Nordiskâ€™s amycretin cuts body weight, blood sugar in Phase 2 diabetes trial](https://endpoints.news/novo-nordisks-amycretin-cuts-body-weight-blood-sugar-in-phase-2-diabetes-trial/)**  
  _Tue, 25 Nov 2025 14:31:02 +0000_  
  Novo Nordiskâ€™s amylin combination shot amycretin allowed patients with diabetes to lose up to 14.5% of their body weight in just over eight months. Patients in the same mid-stage trial who were given a pill ...

- **[Novartis plans to lay off 550 workers at Swiss factory](https://endpoints.news/novartis-plans-to-lay-off-550-workers-at-swiss-factory/)**  
  _Tue, 25 Nov 2025 14:18:48 +0000_  
  Novartis plans to reorganize two Swiss facilities, which it says could result in 550 layoffs as it discontinues some manufacturing at its site in Stein.

 The company intends to discontinue tablet and capsule manufacturing and ...

- **[FDA approves Novartisâ€™ Itvisma for older patients with spinal muscular atrophy](https://endpoints.news/fda-approves-novartis-itvisma-for-older-patients-with-spinal-muscular-atrophy/)**  
  _Tue, 25 Nov 2025 12:09:26 +0000_  
  Novartis has secured FDA approval for a new version of its one-time gene therapy for spinal muscular atrophy (SMA) that it says could benefit a much broader swathe of patients.

 The Swiss drugmaker

- **[Novartis was the sole bidder in $12B deal to buy Avidity](https://endpoints.news/novartis-was-the-sole-bidder-in-12b-deal-to-buy-avidity/)**  
  _Tue, 25 Nov 2025 09:00:28 +0000_  
  It took 14 calls between chief executives, four months of negotiations and four hiked proposals for Novartis and Avidity Biosciences to come to their $12 billion agreement in October, according to a ...

- **[FDA's Pazdur is said to raise questions about commissioners actions, new voucher](https://endpoints.news/fdas-pazdur-is-said-to-raise-questions-about-commissioners-actions-new-voucher/)**  
  _Mon, 24 Nov 2025 21:04:48 +0000_  
  That didn't take long.

 Less than two weeks since appointing Richard Pazdur to lead the FDA's drug center, Commissioner Marty Makary is already finding himself in disagreement with his new deputy, according to two people ...

- **[UK-US drug pricing deal could come as early as this week, sources say](https://endpoints.news/uk-us-drug-pricing-deal-could-come-as-early-as-this-week-sources-say/)**  
  _Mon, 24 Nov 2025 20:53:12 +0000_  
  A major drug price deal between the US and UK government could be finalized as early as this week, two UK-based sources familiar with the matter told Endpoints News on Monday.

 The two governments have ...

- **[#ASH25: Keloniaâ€™s first in vivo CAR-T data; Lilly, J&J and Novartis spell out Phase 3 wins](https://endpoints.news/ash25-kelonias-first-in-vivo-car-t-data-lilly-jj-and-novartis-spell-out-phase-3-wins/)**  
  _Mon, 24 Nov 2025 20:51:46 +0000_  
  Late-breaking abstracts from the annual American Society of Hematology meeting are early this year, coming right before Thanksgiving instead of the previously planned drop on Dec. 1. Big pharma companies are seeking to expand the ...

- **[J&Jâ€™s tau-targeting antibody fails Phase 2 Alzheimer's study](https://endpoints.news/jjs-tau-targeting-antibody-fails-phase-2-alzheimers-study/)**  
  _Mon, 24 Nov 2025 16:22:48 +0000_  
  Johnson & Johnsonâ€™s anti-tau monoclonal antibody failed to slow the progression of Alzheimerâ€™s in patients with early-stage disease, marking the end of one of the company's most promising candidates.

 The company said in a  ...

- **[Kelun's TROP2 ADC plus Keytruda improves outcomes in first-line lung cancer](https://endpoints.news/keluns-trop2-adc-plus-keytruda-improves-outcomes-in-first-line-lung-cancer/)**  
  _Mon, 24 Nov 2025 15:59:45 +0000_  
  Merckâ€™s partner on an experimental antibody-drug conjugate has reported a Phase 3 win in first-line lung cancer, and will take the data to Chinese regulatory authorities.

 Chengdu-based Kelun-Biotech said that a combination of its ADC ...

- **[Sarepta to pay $200M milestone to Arrowhead; Enlivex reports osteoarthritis data](https://endpoints.news/sarepta-to-pay-200m-milestone-payment-to-arrowhead-enlivex-reports-osteoarthritis-data/)**  
  _Mon, 24 Nov 2025 15:39:54 +0000_  
  Plus, news about Clearside Biomedical, Pfizer, Astellas, Merck, MindImmune Therapeutics and Poxel:

 ðŸ’µ Sarepta to pay Arrowhead $200M as it continues type 1 myotonic dystrophy study: Sarepta


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/novo-nordisk-expands-pivotal-amycretin-program-after-dual-agonist-shines-diabetes" hreflang="en">Novo Nordisk expands pivotal amycretin program after dual agonist shines in diabetes</a>](https://www.fiercebiotech.com/biotech/novo-nordisk-expands-pivotal-amycretin-program-after-dual-agonist-shines-diabetes)**  
  _Nov 25, 2025 7:46am_  
  Novo Nordisk is hitting the gas on amycretin development. After posting phase 2 data, the company has decided to run pivotal diabetes trials of an asset that it previously saw primarily as an obesity prospect.

- **[<a href="https://www.fiercebiotech.com/biotech/sarepta-shares-positive-safety-update-dm1-asset-arrowhead-hits-200m-milestone" hreflang="en">Sarepta shares positive safety update on DM1 asset as Arrowhead snares $200M milestone</a>](https://www.fiercebiotech.com/biotech/sarepta-shares-positive-safety-update-dm1-asset-arrowhead-hits-200m-milestone)**  
  _Nov 24, 2025 3:18pm_  
  A drug safety group has delivered a positive analysis for a Sarepta-licensed RNA medicine, with the same study also hitting an enrollment target. The latter development has triggered a $200 milestone payment due to Arrowhead Pharmaceuticals.

- **[<a href="https://www.fiercebiotech.com/biotech/gilead-hatches-400m-biobucks-deal-swedish-biotechs-trex1-cancer-program" hreflang="en">Gilead hatches $400M biobucks deal for Swedish biotechâ€™s TREX1 cancer program</a>](https://www.fiercebiotech.com/biotech/gilead-hatches-400m-biobucks-deal-swedish-biotechs-trex1-cancer-program)**  
  _Nov 24, 2025 12:04pm_  
  Swedish biotech Sprint Bioscience is selling off an early-stage TREX1 cancer program to Gilead for $14 million upfront, plus the chance to net up to $400 million in biobucks.

- **[<a href="https://www.fiercebiotech.com/pharma/novos-shares-tumble-8-after-2-trial-misses-semaglutide-alzheimers-disease" hreflang="en">Novo shares tumble after 2 trial misses for semaglutide in Alzheimer's disease</a>](https://www.fiercebiotech.com/pharma/novos-shares-tumble-8-after-2-trial-misses-semaglutide-alzheimers-disease)**  
  _Nov 24, 2025 11:08am_  
  Novo Nordisk has come up short in two phase 3 trials of semaglutide as a treatment for Alzheimerâ€™s disease. But perhaps the larger story associated with the unsurprising result is the market reaction, as Novo's shares fell by nearly 9% at the U.S. market open Monday.

- **[<a href="https://www.fiercebiotech.com/biotech/versants-dayra-dawns-50m-biogen-pact-oral-macrocyclic-peptide-mission" hreflang="en">Versant's Dayra dawns with $50M Biogen pact, oral macrocyclic peptide mission</a>](https://www.fiercebiotech.com/biotech/versants-dayra-dawns-50m-biogen-pact-oral-macrocyclic-peptide-mission)**  
  _Nov 24, 2025 10:29am_  
  VC Versant Ventures is unveiling Dayra Therapeutics, a new biotech working on oral macrocyclic peptide drugsâ€”a mission that has already reeled in a partnership with Biogen.

- **[<a href="https://www.fiercebiotech.com/biotech/jjs-5b-alzheimers-hope-fades-anti-tau-antibody-posdinemab-flops-phase-2" hreflang="en">J&amp;J's $5B Alzheimer's hope fades as anti-tau antibody posdinemab flops in phase 2</a>](https://www.fiercebiotech.com/biotech/jjs-5b-alzheimers-hope-fades-anti-tau-antibody-posdinemab-flops-phase-2)**  
  _Nov 24, 2025 9:23am_  
  Johnson & Johnsonâ€™s attempt to develop a $5 billion-a-year Alzheimerâ€™s disease drug has been rocked by a phase 2 flop. A scheduled data review found the anti-tau antibody posdinemab failed to significantly slow clinical decline, prompting J&J to stop the study.

- **[<a href="https://www.fiercebiotech.com/medtech/roche-inks-200m-licensing-pact-freenomes-cancer-screening-blood-tests" hreflang="en">Roche inks $200M-plus licensing pact for Freenome's cancer screening blood tests</a>](https://www.fiercebiotech.com/medtech/roche-inks-200m-licensing-pact-freenomes-cancer-screening-blood-tests)**  
  _Nov 21, 2025 10:57am_  
  Roche will make a new $75 million equity investment in Freenome, toward the goal of developing blood testing kits for markets outside the U.S.


## Regeneron Press Releases

- **[DupixentÂ® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)](https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-first-targeted-medicine-european)**  
  _Tue, 25 Nov 2025 01:00:00 -0500_  
  Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite standard-of-care antihistamine treatment


## arXiv q-bio

- **[An Ecologically-Informed Deep Learning Framework for Interpretable and Validatable Habitat Mapping](https://arxiv.org/abs/2511.17627)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.17627v1 Announce Type: new 
Abstract: Benthic habitat is challenging due to the environmental complexity of the seafloor, technological limitations, and elevated operational costs, especially in under-explored regions. This generates knowledge gaps for the sustainable management of hydrobiological resourcesâ€¦

- **[Dual-Path Knowledge-Augmented Contrastive Alignment Network for Spatially Resolved Transcriptomics](https://arxiv.org/abs/2511.17685)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.17685v1 Announce Type: new 
Abstract: Spatial Transcriptomics (ST) is a technology that measures gene expression profiles within tissue sections while retaining spatial context. It reveals localized gene expression patterns and tissue heterogeneity, both of which are essential for understanding disease etioâ€¦

- **[SynCell: Contextualized Drug Synergy Prediction](https://arxiv.org/abs/2511.17695)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.17695v1 Announce Type: new 
Abstract: Motivation: Drug synergy is strongly influenced by cellular context. Variations in protein interaction landscapes and pathway activities across cell types can reshape how drugs act in combination. However, most existing models overlook this heterogeneity and rely on staâ€¦

- **[Complete strategy spaces reveal hidden pathways to cooperation](https://arxiv.org/abs/2511.17794)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.17794v1 Announce Type: new 
Abstract: Understanding how cooperation emerges and persists is a central challenge in evolutionary game theory. Existing models often rely on restricted, hand-picked strategy sets, which can overlook critical behavioural pathways. A recent four-strategy framework showed that cheâ€¦

- **[Canalization as a stabilizing principle of gene regulatory networks: a discrete dynamical systems perspective](https://arxiv.org/abs/2511.17905)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.17905v1 Announce Type: new 
Abstract: Gene regulatory networks exhibit remarkable stability, maintaining functional phenotypes despite genetic and environmental perturbations. Discrete dynamical models, such as Boolean networks, provide systems biologists with a tractable framework to explore the mathematicâ€¦

- **[CLTree: A Tool for Annotating, Rooting, and Evaluating Phylogenetic Trees Leveraging Genomic Lineages](https://arxiv.org/abs/2511.17996)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.17996v1 Announce Type: new 
Abstract: Collapse Lineage Tree (CLTree) is a software tool that annotates, roots, and evaluates phylogenetic trees by using lineages. A recursive algorithm was designed to annotate the branches by the common taxonomic lineage of its descendants in a rooted tree. For an unrootedâ€¦

- **[EscalNet: Learn isotropic representation space for biomolecular dynamics based on effective energy](https://arxiv.org/abs/2511.18010)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18010v1 Announce Type: new 
Abstract: Deep learning has emerged as a powerful framework for analyzing biomolecular dynamics trajectories, enabling efficient representations that capture essential system dynamics and facilitate mechanistic studies. We propose a neural network architecture incorporating Fouriâ€¦

- **[The Hydraulic Brain: Understanding as Constraint-Release Phase Transition in Whole-Body Resonance](https://arxiv.org/abs/2511.18057)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18057v1 Announce Type: new 
Abstract: Current models treat physiological signals as noise corrupting neural computation. Previously, we showed that removing these "artifacts" eliminates 70% of predictive correlation, suggesting body signals functionally drive cognition. Here, we investigate the mechanism usâ€¦

- **[SEIR models with host heterogeneity: theoretical aspects and applications to seasonal influenza dynamics](https://arxiv.org/abs/2511.18142)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18142v1 Announce Type: new 
Abstract: Population heterogeneity is a key factor in epidemic dynamics, influencing both transmission and final epidemic size. While heterogeneity is often modeled through age structure, spatial location, or contact patterns, differences in host susceptibility have recently gainâ€¦

- **[Detecting Discontinuities in the Topology of Alzheimers gene Co-expression](https://arxiv.org/abs/2511.18238)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18238v1 Announce Type: new 
Abstract: Alzheimer's disease (AD) emerges from a complex interplay of molecular, cellular, and network-level disturbances that are not easily captured by traditional reductionist frameworks. Conventional analyses of gene expression often rely on thresholded correlation networksâ€¦

- **[Brain-MGF: Multimodal Graph Fusion Network for EEG-fMRI Brain Connectivity Analysis Under Psilocybin](https://arxiv.org/abs/2511.18325)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18325v1 Announce Type: new 
Abstract: Psychedelics, such as psilocybin, reorganise large-scale brain connectivity, yet how these changes are reflected across electrophysiological (electroencephalogram, EEG) and haemodynamic (functional magnetic resonance imaging, fMRI) networks remains unclear. We present Bâ€¦

- **[Assessing Gaze and Pointing: Human Cue Interpretation by Indian Free-Ranging Dogs in a Food Retrieval Task](https://arxiv.org/abs/2511.18598)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18598v1 Announce Type: new 
Abstract: The urban habitat provides a landscape that increases the chances of human-animal interactions, which can lead to increased human-animal conflict, but also coexistence. Some species show high levels of socio-cognitive abilities that enable them to perceive communicationâ€¦

- **[Learning the principles of T cell antigen discernment](https://arxiv.org/abs/2511.18626)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18626v1 Announce Type: new 
Abstract: T cells are central to the adaptive immune response, capable of detecting pathogenic antigens while ignoring healthy tissues with remarkable specificity and sensitivity. Quantitatively understanding how T cell receptors (TCRs) discriminate among antigens requires biophyâ€¦

- **[On the role of fractional Brownian motion in models of chemotaxis and stochastic gradient ascent](https://arxiv.org/abs/2511.18745)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18745v1 Announce Type: new 
Abstract: Cell migration often exhibits long-range temporal correlations and anomalous diffusion, even in the absence of external guidance cues such as chemical gradients or topographical constraints. These observations raise a fundamental question: do such correlations simply reâ€¦

- **[Decoding the science behind antioxidant -antiinflammatory nutraceuticals in stroke](https://arxiv.org/abs/2511.18853)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18853v1 Announce Type: new 
Abstract: Stroke is a leading cause of disability and death worldwide, with ischemic strokes accounting for nearly 80% of cases. Fewer than 5% of patients receive the sole validated pharmacotherapy, intravenous thrombolysis, highlighting the urgent need for novel therapies. Withiâ€¦

- **[A universal phase-plane model for in vivo protein aggregation](https://arxiv.org/abs/2511.18893)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18893v1 Announce Type: new 
Abstract: Neurodegenerative diseases are driven by the accumulation of protein aggregates in the brain of affected individuals. The aggregation behaviour in vitro is well understood and driven by the equilibration of a super-saturated protein solution to its aggregated equilibriuâ€¦

- **[The TAG array of a multiple sequence alignment](https://arxiv.org/abs/2511.19068)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.19068v1 Announce Type: new 
Abstract: Modern genomic analyses increasingly rely on pangenomes, that is, representations of the genome of entire populations. The simplest representation of a pangenome is a set of individual genome sequences. Compared to e.g. sequence graphs, this has the advantage that efficâ€¦

- **[Many-Eyes and Sentinels in Selfish and Cooperative Groups](https://arxiv.org/abs/2511.19093)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.19093v1 Announce Type: new 
Abstract: Collective vigilance describes how animals in groups benefit from the predator detection efforts of others. Empirical observations typically find either a many-eyes strategy with all (or many) group members maintaining a low level of individual vigilance, or a sentinelâ€¦

- **[Torsion-Space Diffusion for Protein Backbone Generation with Geometric Refinement](https://arxiv.org/abs/2511.19184)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.19184v1 Announce Type: new 
Abstract: Designing new protein structures is fundamental to computational biology, enabling advances in therapeutic molecule discovery and enzyme engineering. Existing diffusion-based generative models typically operate in Cartesian coordinate space, where adding noise disruptsâ€¦

- **[Beyond Protein Language Models: An Agentic LLM Framework for Mechanistic Enzyme Design](https://arxiv.org/abs/2511.19423)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.19423v1 Announce Type: new 
Abstract: We present Genie-CAT, a tool-augmented large-language-model (LLM) system designed to accelerate scientific hypothesis generation in protein design. Using metalloproteins (e.g., ferredoxins) as a case study, Genie-CAT integrates four capabilities -- literature-grounded râ€¦

- **[RTMol: Rethinking Molecule-text Alignment in a Round-trip View](https://arxiv.org/abs/2511.12135)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.12135v2 Announce Type: cross 
Abstract: Aligning molecular sequence representations (e.g., SMILES notations) with textual descriptions is critical for applications spanning drug discovery, materials design, and automated chemical literature analysis. Existing methodologies typically treat molecular captioniâ€¦

- **[AI-driven Generation of MALDI-TOF MS for Microbial Characterization](https://arxiv.org/abs/2511.17611)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.17611v1 Announce Type: cross 
Abstract: Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) has become a cornerstone technology in clinical microbiology, enabling rapid and accurate microbial identification. However, the development of data-driven diagnostic models reâ€¦

- **[Data-Driven Predictive Modeling of Microfluidic Cancer Cell Separation Using a Deterministic Lateral Displacement Device](https://arxiv.org/abs/2511.17787)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.17787v1 Announce Type: cross 
Abstract: Deterministic Lateral Displacement (DLD) devices are widely used in microfluidics for label-free, size-based separation of particles and cells, with particular promise in isolating circulating tumor cells (CTCs) for early cancer diagnostics. This study focuses on theâ€¦

- **[Reward Engineering for Spatial Epidemic Simulations: A Reinforcement Learning Platform for Individual Behavioral Learning](https://arxiv.org/abs/2511.18000)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18000v1 Announce Type: cross 
Abstract: We present ContagionRL, a Gymnasium-compatible reinforcement learning platform specifically designed for systematic reward engineering in spatial epidemic simulations. Unlike traditional agent-based models that rely on fixed behavioral rules, our platform enables rigoâ€¦

- **[A Lightweight, Interpretable Deep Learning System for Automated Detection of Cervical Adenocarcinoma In Situ (AIS)](https://arxiv.org/abs/2511.18063)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18063v1 Announce Type: cross 
Abstract: Cervical adenocarcinoma in situ (AIS) is a critical premalignant lesion whose accurate histopathological diagnosis is challenging. Early detection is essential to prevent progression to invasive cervical adenocarcinoma. In this study, we developed a deep learning-baseâ€¦

- **[TRIDENT: A Trimodal Cascade Generative Framework for Drug and RNA-Conditioned Cellular Morphology Synthesis](https://arxiv.org/abs/2511.18287)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18287v1 Announce Type: cross 
Abstract: Accurately modeling the relationship between perturbations, transcriptional responses, and phenotypic changes is essential for building an AI Virtual Cell (AIVC). However, existing methods typically constrained to modeling direct associations, such as Perturbation $\râ€¦

- **[MultiDiffNet: A Multi-Objective Diffusion Framework for Generalizable Brain Decoding](https://arxiv.org/abs/2511.18294)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18294v1 Announce Type: cross 
Abstract: Neural decoding from electroencephalography (EEG) remains fundamentally limited by poor generalization to unseen subjects, driven by high inter-subject variability and the lack of large-scale datasets to model it effectively. Existing methods often rely on synthetic sâ€¦

- **[Auxiliary Gene Learning: Spatial Gene Expression Estimation by Auxiliary Gene Selection](https://arxiv.org/abs/2511.18336)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.18336v1 Announce Type: cross 
Abstract: Spatial transcriptomics (ST) is a novel technology that enables the observation of gene expression at the resolution of individual spots within pathological tissues. ST quantifies the expression of tens of thousands of genes in a tissue section; however, heavy observaâ€¦

- **[Fast and Flexible Flow Decompositions in General Graphs via Dominators](https://arxiv.org/abs/2511.19153)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.19153v1 Announce Type: cross 
Abstract: Multi-assembly methods rely at their core on a flow decomposition problem, namely, decomposing a weighted graph into weighted paths or walks. However, most results over the past decade have focused on decompositions over directed acyclic graphs (DAGs). This limitationâ€¦

- **[Interpreting GFlowNets for Drug Discovery: Extracting Actionable Insights for Medicinal Chemistry](https://arxiv.org/abs/2511.19264)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2511.19264v1 Announce Type: cross 
Abstract: Generative Flow Networks, or GFlowNets, offer a promising framework for molecular design, but their internal decision policies remain opaque. This limits adoption in drug discovery, where chemists require clear and interpretable rationales for proposed structures. Weâ€¦

- **[Robust Core-Periphery Constrained Transformer for Domain Adaptation](https://arxiv.org/abs/2308.13515)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2308.13515v5 Announce Type: replace 
Abstract: Unsupervised domain adaptation (UDA) aims to learn transferable representation across domains. Recently a few UDA works have successfully applied Transformer-based methods and achieved state-of-the-art (SOTA) results. However, it remains challenging when there existâ€¦

- **[Perceptogram: Reconstructing Visual Percepts and Presumptive Electrode Preference from EEG](https://arxiv.org/abs/2404.01250)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2404.01250v3 Announce Type: replace 
Abstract: Visual neural decoding from EEG has improved significantly due to diffusion models that can reconstruct high-quality images from decoded latents. While recent works have focused on relatively complex architectures to achieve good reconstruction performance from EEG,â€¦

- **[Predictability of viral load dynamics in the early phases of SARS-CoV-2 through a model-based approach](https://arxiv.org/abs/2407.03158)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2407.03158v3 Announce Type: replace 
Abstract: A pipeline to evaluate the evolution of viral dynamics based on a new model-driven approach has been developed in the present study. The proposed methods exploit real data and the multiscale structure of the infection dynamics to provide robust predictions of the epâ€¦

- **[Evolutionarily stable strategy in asymmetric games: Dynamical and information-theoretical perspectives](https://arxiv.org/abs/2409.19320)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2409.19320v4 Announce Type: replace 
Abstract: Evolutionarily stable strategy (ESS) is the defining concept of evolutionary game theory. It has a fairly unanimously accepted definition for the case of symmetric games which are played in a homogeneous population where all individuals are in same role. However, inâ€¦

- **[A phenotype-structured mathematical model for the influence of hypoxia on oncolytic virotherapy](https://arxiv.org/abs/2411.02413)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2411.02413v2 Announce Type: replace 
Abstract: The effectiveness of oncolytic virotherapy is significantly affected by several elements of the tumour microenvironment, which reduce the ability of the virus to infect cancer cells. In this work, we focus on the influence of hypoxia on this therapy and develop a noâ€¦

- **[Leveraging genomic deep learning models for the prediction of non-coding variant effects](https://arxiv.org/abs/2411.11158)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2411.11158v2 Announce Type: replace 
Abstract: Characterizing non-coding variant function remains an important challenge in human genetics. Genomic deep learning models have emerged as a promising approach to enable in silico prediction of variant effects. These include supervised sequence-to-activity models, whâ€¦

- **[Mathematical Insights into Protein Architecture: Persistent Homology and Machine Learning Applied to the Flagellar Motor](https://arxiv.org/abs/2504.16941)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2504.16941v3 Announce Type: replace 
Abstract: We present a machine learning approach that leverages persistent homology to classify bacterial flagellar motors into two functional states: rotated and stalled. By embedding protein structural data into a topological framework, we extract multiscale features from fâ€¦

- **[KINDLE: Knowledge-Guided Distillation for Prior-Free Gene Regulatory Network Inference](https://arxiv.org/abs/2505.09664)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2505.09664v2 Announce Type: replace 
Abstract: Gene regulatory network (GRN) inference serves as a cornerstone for deciphering cellular decision-making processes. Early approaches rely exclusively on gene expression data, thus their predictive power remain fundamentally constrained by the vast combinatorial spacâ€¦

- **[Deep Learning for Blood-Brain Barrier Permeability Prediction](https://arxiv.org/abs/2507.18557)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2507.18557v3 Announce Type: replace 
Abstract: Predicting whether a molecule can cross the blood-brain barrier (BBB) is a key step in early-stage neuropharmaceutical development, directly influencing both research efficiency and success rates in drug discovery. Traditional empirical methods based on physicochemiâ€¦

- **[Gradient Propagation in Retrosynthetic Space: An Efficient Framework for Synthesis Plan Generation](https://arxiv.org/abs/2405.16123)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2405.16123v2 Announce Type: replace-cross 
Abstract: Retrosynthesis, which aims to identify viable synthetic pathways for target molecules by decomposing them into simpler precursors, is often treated as a search problem. However, its complexity arises from multi-branched tree-structured pathways rather than linâ€¦

- **[Adapting Physics-Informed Neural Networks for Bifurcation Detection in Ecological Migration Models](https://arxiv.org/abs/2409.00651)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2409.00651v2 Announce Type: replace-cross 
Abstract: In this study, we explore the application of Physics-Informed Neural Networks (PINNs) to the analysis of bifurcation phenomena in ecological migration models. By integrating the fundamental principles of diffusion-advection-reaction equations with deep learninâ€¦

- **[Functional Classification of Spiking Signal Data Using Artificial Intelligence Techniques: A Review](https://arxiv.org/abs/2409.17516)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2409.17516v2 Announce Type: replace-cross 
Abstract: Human brain neuron activities are incredibly significant nowadays. Neuronal behavior is assessed by analyzing signal data such as electroencephalography (EEG), which can offer scientists valuable information about diseases and human-computer interaction. One oâ€¦

- **[Classification of autoimmune diseases from Peripheral blood TCR repertoires by multimodal multi-instance learning](https://arxiv.org/abs/2507.04981)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2507.04981v4 Announce Type: replace-cross 
Abstract: T cell receptor (TCR) repertoires encode critical immunological signatures for autoimmune diseases, yet their clinical application remains limited by sequence sparsity and low witness rates. We developed EAMil, a multi-instance deep learning framework that levâ€¦

- **[Learning Potential Energy Surfaces of Hydrogen Atom Transfer Reactions in Peptides](https://arxiv.org/abs/2508.00578)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2508.00578v2 Announce Type: replace-cross 
Abstract: Hydrogen atom transfer (HAT) reactions are essential in many biological processes, such as radical migration in damaged proteins, but their mechanistic pathways remain incompletely understood. Simulating HAT is challenging due to the need for quantum chemicalâ€¦

- **[Investigating the consequences of mechanical ventilation in clinical intensive care settings through an evolutionary game-theoretic framework](https://arxiv.org/abs/2510.15127)**  
  _Tue, 25 Nov 2025 00:00:00 -0500_  
  arXiv:2510.15127v2 Announce Type: replace-cross 
Abstract: Identifying the effects of mechanical ventilation strategies and protocols in critical care requires analyzing data from heterogeneous patient-ventilator systems within the context of the clinical decision-making environment. This research develops a frameworkâ€¦
